GB857081A - Cyclopentanophenanthrene derivatives and process for the production thereof - Google Patents
Cyclopentanophenanthrene derivatives and process for the production thereofInfo
- Publication number
- GB857081A GB857081A GB16963/57A GB1696357A GB857081A GB 857081 A GB857081 A GB 857081A GB 16963/57 A GB16963/57 A GB 16963/57A GB 1696357 A GB1696357 A GB 1696357A GB 857081 A GB857081 A GB 857081A
- Authority
- GB
- United Kingdom
- Prior art keywords
- methyl
- estrone
- dehydro
- estradiol
- ethinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Abstract
The invention comprises 2-methyl-estrone, 2-methyl-estradiol, 2-methyl-17a -ethinyl-estra-diol, the corresponding 6-dehydro compounds; their esters with hydrocarbon carboxylic acids containing less than twelve carbon atoms, and a process for the preparation of 2-methyl-6-dehydro-estrone by heating 2-methyl-D 1,4,6-androstatriene-3,17-dione at approximately 600 DEG C, preferably in a hydrogen donor solvent, e.g., mineral oil, dihydro-or tetrahydro-naphthalene, dihydrophenanthrene and cyclohexene. The product may then be reduced, e.g. with sodium borohydride or lithium aluminium hydride to the diol, or reacted with potassium acetylide giving the 17a -ethinyl-17b -ol derivative, or hydrogenated, preferably over palladium or platinum, to 2-methyl-estrone and then treated as above. In Examples :-(1) 2-methyl-D 1,4,6-androstatriene-3, 17-dione in mineral oil is passed through a column of glass helices at 600 DEG C., the product diluted with hexane and chromatographed on alumina, washed well with hexane and 2-methyl-6-dehydro-estrone eluted with ether, and characterised as its 3-propionate, benzoate, cyclopentylpropionate and phenylpropionate; (2) reduction of 2-methyl-6-de-hydro-estrone with aqueous methanolic sodium borohydride gives 2-methyl-6-dehydro-estradiol, characterised as its 3, 17-dipropionate, dibenzoate, di-cyclopentylpropionate and diphenylpropionate; (3) 2-methyl-6-dehydro-estrone in benzene is treated under nitrogen with potassium in t-butanol and acetylene passed into the mixture giving 2-methyl-17a -ethinyl-6-dehydro-estradiol, which is esterified as above; (4) hydrogenation of 2-methyl-6-dehydro-estrone in ethyl acetate over 10 per cent. palladium-charcoal yields 2-methyl-estrone, which is reduced with sodium borohydride to 2-methyl-estradiol, and (5) treated with potassium acetylide as in (3) giving 2-methyl-17a -ethinyl-estradiol, the corresponding esters being also prepared. Specification 857,080 is referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX857081X | 1956-05-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB857081A true GB857081A (en) | 1960-12-29 |
Family
ID=19743112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB16963/57A Expired GB857081A (en) | 1956-05-29 | 1957-05-28 | Cyclopentanophenanthrene derivatives and process for the production thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB857081A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002042319A2 (en) * | 2000-11-27 | 2002-05-30 | Entremed, Inc. | 2-substituted estrogens as antiangiogenic agents |
US6723858B2 (en) | 1993-08-06 | 2004-04-20 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
WO2006003013A2 (en) * | 2004-07-02 | 2006-01-12 | Bayer Schering Pharma Aktiengesellschaft | NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1 |
US7012070B2 (en) | 1993-08-06 | 2006-03-14 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
US7135581B2 (en) | 2000-08-18 | 2006-11-14 | Entremed, Inc. | Antiangiogenic agents |
US7419972B2 (en) | 2004-07-02 | 2008-09-02 | Schering Ag | 2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 |
US7867975B2 (en) | 1995-10-23 | 2011-01-11 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
US8158612B2 (en) | 2004-03-12 | 2012-04-17 | Entremed, Inc. | Methods of treating disease states using antiangiogenic agents |
US8399440B2 (en) | 2006-03-20 | 2013-03-19 | Entremed, Inc. | Disease modifying anti-arthritic activity of 2-methoxyestradiol |
-
1957
- 1957-05-28 GB GB16963/57A patent/GB857081A/en not_active Expired
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7081477B2 (en) | 1993-08-06 | 2006-07-25 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
US7109187B2 (en) | 1993-08-06 | 2006-09-19 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
US7381848B2 (en) | 1993-08-06 | 2008-06-03 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
US6930128B2 (en) | 1993-08-06 | 2005-08-16 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
US7291610B2 (en) | 1993-08-06 | 2007-11-06 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
US7012070B2 (en) | 1993-08-06 | 2006-03-14 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
US6723858B2 (en) | 1993-08-06 | 2004-04-20 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
US7867975B2 (en) | 1995-10-23 | 2011-01-11 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
US7235540B2 (en) | 1999-08-23 | 2007-06-26 | Entremed, Inc. | Methods of using 2-methoxyestradiol of high purity |
US7135581B2 (en) | 2000-08-18 | 2006-11-14 | Entremed, Inc. | Antiangiogenic agents |
WO2002042319A3 (en) * | 2000-11-27 | 2003-03-13 | Entremed Inc | 2-substituted estrogens as antiangiogenic agents |
WO2002042319A2 (en) * | 2000-11-27 | 2002-05-30 | Entremed, Inc. | 2-substituted estrogens as antiangiogenic agents |
US8158612B2 (en) | 2004-03-12 | 2012-04-17 | Entremed, Inc. | Methods of treating disease states using antiangiogenic agents |
WO2006003013A2 (en) * | 2004-07-02 | 2006-01-12 | Bayer Schering Pharma Aktiengesellschaft | NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1 |
US7419972B2 (en) | 2004-07-02 | 2008-09-02 | Schering Ag | 2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 |
WO2006003013A3 (en) * | 2004-07-02 | 2006-06-22 | Schering Ag | NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1 |
US8399440B2 (en) | 2006-03-20 | 2013-03-19 | Entremed, Inc. | Disease modifying anti-arthritic activity of 2-methoxyestradiol |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB857081A (en) | Cyclopentanophenanthrene derivatives and process for the production thereof | |
US2877221A (en) | 11, 14-peroxides of substituted ergostadiene compounds | |
US3465010A (en) | 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof | |
Doss et al. | Sterols in marine invertebrates. 60. Isolation and structure elucidation of four new steroidal cyclopropenes from the sponge Calyx podatypa | |
US2697106A (en) | Selective reduction of 3 keto delta4,6 steroids | |
Hirschmann et al. | C-22 ketals related to the sapogenins | |
GB864926A (en) | Process for preparing novel compounds of the lactone type | |
US3435030A (en) | 17-alkenyl/alkynyl-5alpha-androst - 1 - ene-3beta,17beta-diols,esters thereof and interme-diates thereto | |
US3080399A (en) | Cyclopentanophenanthrene compounds and process | |
Just et al. | Steroids and Related Products. IX. 1 The Introduction of the▵ 11-Double Bond. I2 | |
Baker et al. | New method for the preparation of unsaturated axial 3-sterols | |
US2833763A (en) | delta-allopregnadiene-3beta, 21-diol-20-one 11, 14 peroxide and esters thereof | |
US3270007A (en) | Process for cyclopentanophenanthrene compounds | |
US3629301A (en) | 3 3-difluoro-2-substituted steroids and their preparation | |
US2833762A (en) | delta-allopregnadiene-3beta-ol-20-one 11, 14-peroxide and esters thereof | |
GB744237A (en) | Cyclopentanophenanthrene compounds and process for the production thereof | |
US3450720A (en) | 3-difluoromethylene steroids | |
US3412108A (en) | A-homo-delta1(10), 2, 4alpha(5)-estratrien-4-ones and their preparation | |
Wolff et al. | Ring A Aromatization of a 19-Norsteroid | |
US3002007A (en) | Oxygenated derivatives of 4-methylestranes | |
GB1176229A (en) | Preparation of Ethynyl Hydroxy Steroids | |
US3261855A (en) | Method for the preparation of delta5(10)-steroids | |
US3641006A (en) | Process for the preparation of steroid alpha-fluoronitrimines | |
US2741626A (en) | Hydroxylated steroids | |
US3472883A (en) | Process for preparing estren-3-ones |